Abstract
Purpose
This study evaluated the long-term (5-year) durability of radiofrequency energy delivery for fecal incontinence.
Methods
This was an extension of the follow-up from our original prospective study in which patients who suffered from fecal incontinence were treated with the SECCA® system for radiofrequency energy delivery to the anal canal muscle. The Cleveland Clinic Florida Fecal Incontinence Scale (0–20), fecal incontinence-related quality of life score, and Medical Outcomes Study Short-Form 36 were administered to five years. Differences between baseline and follow-up were analyzed by using paired t-test.
Results
A total of 19 patients were treated and followed for five years, including 18 females (aged 57.1 (range, 44–77) years). The mean duration for fecal incontinence was 7.1 (range, 1–21) years. At five-year follow-up, the mean fecal incontinence score had improved from 14.37 to 8.26 (P < 0.00025) with 16 patients (84.2 percent) demonstrating >50 percent improvement. All fecal incontinence-related quality of life scores improved, including lifestyle (2.43 to 3.15; P < 0.00075), coping (1.73 to 2.6; P < 0.00083), depression (2.24 to 3.15; P < 0.0002), and embarrassment (1.56 to 2.51; P < 0.0003). The social function component of the Short-Form 36 improved from 38.3 to 60 (P < 0.05). There was a trend toward improvement in the mental component summary of the Short-Form 36 from 38.1 to 48.14. There were no long-term complications.
Conclusions
Significant and sustained improvements in fecal incontinence symptoms and quality of life are seen at five years after treatment with the SECCA® system. This treatment should be considered for patients suffering from fecal incontinence not amenable to surgery and who have failed conservative management.
Similar content being viewed by others
References
MacLennan AH, Wilson DH, Wilson D. The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. Br J Obstet Gynaecol 2000;107:1460–70.
Macmillan KA, Merrie AE, Marshall R, Bryan R. The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature. Dis Colon Rectum 2004;47:1341–9.
Rockwood TH, Church JM, Fleshman JW, et al. Fecal Incontinence Quality of Life Scale. Quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 2000;43:9–17.
Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993;36:77–97.
Whitehead WE, Wald A, Norton NJ. Treatment options for fecal incontinence. Dis Colon Rectum 2001;44:131–44.
Kalantar JS, Howell S, Talley NJ. Prevalence of faecal incontinence in adults aged 40 years or more living in a community. Gut 2002;50:480–4.
Nakanishi N, Tatara K, Nakajima K, et al. Urinary and fecal incontinence in a community residing elderly population, prevelance, correlates and prognosis [in Japanese]. Nippon Koshu Elsei Zasshi 1997;44:192–200.
Rudolph W, Galandiuk S. A practical guide to the diagnosis and management of fecal incontinence. Mayo Clin Proc 2002;45:915–22.
Wong WD, Congliosi SM, Spencer MP, et al. The safety and efficacy of the artificial bowel sphincter for fecal incontinence: results from a multicenter cohort study. Dis Colon Rectum 2002;45:1139–53.
Malouf AJ, Vaizey CJ, Nicholls J, Kamm MA. Permanent sacral nerve stimulation for fecal incontinence. Ann Surg 2000;232:143–8
Conaghan P, Farouk R. Sacral nerve stimulation can be successful in patients with ultrasound evidence of external anal sphincter disruption. Dis Colon Rectum 2005;48:1610–4.
Takahashi T, Garcia-Osogobio S, Valdovinos MA, et al. Radio-frequency energy delivery to the anal canal for the treatment of fecal incontinence. Dis Colon Rectum 2002;45:915–9.
Takahashi T, Garcia-Osogobio S, Valdovinos MA, et al. Extended two-year results of radio-frequency energy delivery for the treatment of fecal incontinence. Dis Colon Rectum 2003;46:711–5.
Efron JE, Corman ML, Fleshman J, et al. Safety and effectiveness of temperature-controlled radio-frequency energy delivery to the anal canal (Secca® procedure) for the treatment of fecal incontinence. Dis Colon Rectum 2003;46:1606–18.
Parisien CJ, Corman ML. The Secca procedure for the treatment of fecal incontinence: definitive therapy or short-term solution. Clin Colon Rectal Surg 2005;18:42–5.
McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item health survey (SF-36): tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40–66.
Norton C, Chelvanavagam S, Wilson-Barnett J, Redfern S, Kamm MA. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology 2003;125:1320–9.
Gilliland R, Altomare DF, Moreira H Jr, Oliveira L, Gilleland JE, Wexner SD. Pudendal neuropathy is predictive of failure following anterior overlapping sphincteroplasty. Dis Colon Rectum 1998;41:1516–22.
Halverson AL, Hull TL. Long-term outcome of overlapping anal sphincter repair. Dis Colon Rectum 2002;45:345–8.
Rao SS. American College of Gastroenterology Practice Parameters Committee. Diagnosis and management of fecal incontinence. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 2004,99:1585–604.
Khaikin M, Wexner S. Treatment strategies in obstructed defecation and fecal incontinence. World J Gastroenterol 2006;12:3168–73.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Takahashi-Monroy, T., Morales, M., Garcia-Osogobio, S. et al. SECCA® Procedure for the Treatment of Fecal Incontinence: Results of Five-Year Follow-Up. Dis Colon Rectum 51, 355–359 (2008). https://doi.org/10.1007/s10350-007-9169-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-007-9169-0